65 related articles for article (PubMed ID: 1328848)
1. Metabolic pathways for the activation of the antiviral agent 2',3'-dideoxyguanosine in human lymphoid cells.
Bondoc LL; Ahluwalia G; Cooney DA; Hartman NR; Johns DG; Fridland A
Mol Pharmacol; 1992 Sep; 42(3):525-30. PubMed ID: 1328848
[TBL] [Abstract][Full Text] [Related]
2. Tiazofurin metabolism in human lymphoblastoid cells: evidence for phosphorylation by adenosine kinase and 5'-nucleotidase.
Fridland A; Connelly MC; Robbins TJ
Cancer Res; 1986 Feb; 46(2):532-7. PubMed ID: 3000575
[TBL] [Abstract][Full Text] [Related]
3. Identification of the mechanism of activation of 9-beta-D-arabinofuranosyladenine in human lymphoid cells using mutants deficient in nucleoside kinases.
Verhoef V; Sarup J; Fridland A
Cancer Res; 1981 Nov; 41(11 Pt 1):4478-83. PubMed ID: 6272978
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of 2',3'-dideoxyinosine by cytosolic 5'-nucleotidase of human lymphoid cells.
Johnson MA; Fridland A
Mol Pharmacol; 1989 Aug; 36(2):291-5. PubMed ID: 2549385
[TBL] [Abstract][Full Text] [Related]
5. 2',3'-Dideoxycytidine toxicity in cultured human CEM T lymphoblasts: effects of combination with 3'-azido-3'-deoxythymidine and thymidine.
Törnevik Y; Eriksson S
Mol Pharmacol; 1990 Aug; 38(2):237-43. PubMed ID: 2166904
[TBL] [Abstract][Full Text] [Related]
6. Metabolism of the carbocyclic nucleoside analogue carbovir, an inhibitor of human immunodeficiency virus, in human lymphoid cells.
Bondoc LL; Shannon WM; Secrist JA; Vince R; Fridland A
Biochemistry; 1990 Oct; 29(42):9839-43. PubMed ID: 2271622
[TBL] [Abstract][Full Text] [Related]
7. 2',3'-Dideoxycytidine: regulation of its metabolism and anti-retroviral potency by natural pyrimidine nucleosides and by inhibitors of pyrimidine nucleotide synthesis.
Balzarini J; Cooney DA; Dalal M; Kang GJ; Cupp JE; DeClercq E; Broder S; Johns DG
Mol Pharmacol; 1987 Dec; 32(6):798-806. PubMed ID: 2826994
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationships for phosphorylation of nucleoside analogs to monophosphates by nucleoside kinases.
Johansson NG; Eriksson S
Acta Biochim Pol; 1996; 43(1):143-60. PubMed ID: 8790720
[TBL] [Abstract][Full Text] [Related]
9. Adenosine metabolism in wild-type and enzyme-deficient variants of Chinese hamster ovary and Novikoff rat hepatoma cells.
Plagemann PG; Wohlhueter RM
J Cell Physiol; 1983 Aug; 116(2):236-46. PubMed ID: 6306018
[TBL] [Abstract][Full Text] [Related]
10. 2'-Fluoro-2',3'-dideoxyarabinosyladenine: a metabolically stable analogue of the antiretroviral agent 2',3'-dideoxyadenosine.
Masood R; Ahluwalia GS; Cooney DA; Fridland A; Marquez VE; Driscoll JS; Hao Z; Mitsuya H; Perno CF; Broder S
Mol Pharmacol; 1990 Apr; 37(4):590-6. PubMed ID: 2109183
[TBL] [Abstract][Full Text] [Related]
11. Substrate specificity of human deoxycytidine kinase toward antiviral 2',3'-dideoxynucleoside analogs.
Kierdaszuk B; Bohman C; Ullman B; Eriksson S
Biochem Pharmacol; 1992 Jan; 43(2):197-206. PubMed ID: 1739408
[TBL] [Abstract][Full Text] [Related]
12. A human T lymphoid cell variant resistant to the acyclic nucleoside phosphonate 9-(2-phosphonylmethoxyethyl)adenine shows a unique combination of a phosphorylation defect and increased efflux of the agent.
Robbins BL; Connelly MC; Marshall DR; Srinivas RV; Fridland A
Mol Pharmacol; 1995 Feb; 47(2):391-7. PubMed ID: 7870049
[TBL] [Abstract][Full Text] [Related]
13. [Special function of deoxycytidine kinase (dCK) in the activation of chemotherapeutic nucleoside analogs and in the inhibition of cell proliferation].
Staub M
Magy Onkol; 2004; 48(3):229-34. PubMed ID: 15520873
[TBL] [Abstract][Full Text] [Related]
14. Membrane-permeable dideoxyuridine 5'-monophosphate analogue inhibits human immunodeficiency virus infection.
Sastry JK; Nehete PN; Khan S; Nowak BJ; Plunkett W; Arlinghaus RB; Farquhar D
Mol Pharmacol; 1992 Mar; 41(3):441-5. PubMed ID: 1372082
[TBL] [Abstract][Full Text] [Related]
15. Metabolic pathways for the activation of the antiretroviral agent 2',3'-dideoxyadenosine in human lymphoid cells.
Johnson MA; Ahluwalia G; Connelly MC; Cooney DA; Broder S; Johns DG; Fridland A
J Biol Chem; 1988 Oct; 263(30):15354-7. PubMed ID: 3262616
[TBL] [Abstract][Full Text] [Related]
16. Genetic analysis of 2',3'-dideoxycytidine incorporation into cultured human T lymphoblasts.
Ullman B; Coons T; Rockwell S; McCartan K
J Biol Chem; 1988 Sep; 263(25):12391-6. PubMed ID: 2842332
[TBL] [Abstract][Full Text] [Related]
17. Characterization of an adenosine deaminase-deficient human histiocytic lymphoma cell line (DHL-9) and selection of mutants deficient in adenosir kinase and deoxycytidine kinase.
Kubota M; Kamatani N; Daddona PE; Carson DA
Cancer Res; 1983 Jun; 43(6):2606-10. PubMed ID: 6303563
[TBL] [Abstract][Full Text] [Related]
18. Deoxycytidine and 2',3'-dideoxycytidine metabolism in human monocyte-derived macrophages. A study of both anabolic and catabolic pathways.
Arnér ES; Eriksson S
Biochem Biophys Res Commun; 1993 Dec; 197(3):1499-504. PubMed ID: 8280167
[TBL] [Abstract][Full Text] [Related]
19. Cytostatic effects of 2',3'-dideoxyribonucleosides on transformed human hemopoietic cell lines.
Blakley RL; Harwood FC; Huff KD
Mol Pharmacol; 1990 Feb; 37(2):328-32. PubMed ID: 2154678
[TBL] [Abstract][Full Text] [Related]
20. Kinetic analysis of human deoxycytidine kinase with the true phosphate donor uridine triphosphate.
Hughes TL; Hahn TM; Reynolds KK; Shewach DS
Biochemistry; 1997 Jun; 36(24):7540-7. PubMed ID: 9200705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
